NASDAQ:HSCS Heart Test Laboratories (HSCS) Stock Price, News & Analysis $3.82 0.00 (0.00%) Closing price 02/12/2025 03:54 PM EasternExtended Trading$3.80 -0.01 (-0.39%) As of 08:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends About Heart Test Laboratories Stock (NASDAQ:HSCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HSCS alerts:Sign Up Key Stats Today's Range$3.66▼$3.8850-Day Range$3.22▼$4.4752-Week Range$2.36▼$18.50Volume10,059 shsAverage Volume17,597 shsMarket Capitalization$3.74 millionP/E RatioN/ADividend YieldN/APrice Target$13.50Consensus RatingBuy Company OverviewHeart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Read More… Heart Test Laboratories Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks62nd Percentile Overall ScoreHSCS MarketRank™: Heart Test Laboratories scored higher than 62% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingHeart Test Laboratories has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageHeart Test Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Heart Test Laboratories' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Heart Test Laboratories are expected to grow in the coming year, from ($10.01) to ($8.80) per share.Price to Book Value per Share RatioHeart Test Laboratories has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Heart Test Laboratories' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.05% of the float of Heart Test Laboratories has been sold short.Short Interest Ratio / Days to CoverHeart Test Laboratories has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Heart Test Laboratories has recently decreased by 13.51%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHeart Test Laboratories does not currently pay a dividend.Dividend GrowthHeart Test Laboratories does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.05% of the float of Heart Test Laboratories has been sold short.Short Interest Ratio / Days to CoverHeart Test Laboratories has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Heart Test Laboratories has recently decreased by 13.51%, indicating that investor sentiment is improving significantly. News and Social Media2.0 / 5News SentimentN/A News SentimentHeart Test Laboratories has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Heart Test Laboratories this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Heart Test Laboratories insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.80% of the stock of Heart Test Laboratories is held by insiders.Percentage Held by InstitutionsOnly 17.24% of the stock of Heart Test Laboratories is held by institutions.Read more about Heart Test Laboratories' insider trading history. Receive HSCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address HSCS Stock News HeadlinesShort Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Increases By 6.1%February 4, 2025 | americanbankingnews.comHeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial ResultsDecember 16, 2024 | globenewswire.comStarting 2025 Strong: 2 AI Stocks Under $10 You Can’t MissAs we step into 2025, artificial intelligence (AI) continues to revolutionize industries with groundbreaking advancements. From the surge in generative AI technologies transforming creative processes to AI-driven automation enhancing operational efficiencies, the landscape is brimming with innovation. These rapid developments are creating lucrative opportunities for investors who recognize the potential of emerging AI companies.February 13, 2025 | Darwin (Ad)HeartSciences Inc. HSCS (U.S.: Nasdaq)November 23, 2024 | wsj.comHeart Test announces CMS included AI-ECG tech in 2025 OPPS final ruleNovember 14, 2024 | markets.businessinsider.comHeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid ReimbursementNovember 13, 2024 | globenewswire.comHeartSciences to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 14, 2024 | globenewswire.comAdvocate for Your Future Health With Cholesterol TestingSeptember 25, 2024 | usatoday.comSee More Headlines HSCS Stock Analysis - Frequently Asked Questions How have HSCS shares performed this year? Heart Test Laboratories' stock was trading at $3.82 at the beginning of the year. Since then, HSCS shares have increased by 0.0% and is now trading at $3.82. View the best growth stocks for 2025 here. How were Heart Test Laboratories' earnings last quarter? Heart Test Laboratories, Inc. (NASDAQ:HSCS) issued its quarterly earnings results on Monday, December, 16th. The company reported ($2.27) earnings per share for the quarter, beating analysts' consensus estimates of ($2.30) by $0.03. When did Heart Test Laboratories' stock split? Heart Test Laboratories shares reverse split on Friday, May 17th 2024. The 1-100 reverse split was announced on Friday, May 17th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did Heart Test Laboratories IPO? Heart Test Laboratories (HSCS) raised $9 million in an initial public offering on Wednesday, June 15th 2022. The company issued 1,800,000 shares at a price of $4.50-$5.50 per share. The Benchmark Company acted as the underwriter for the IPO. How do I buy shares of Heart Test Laboratories? Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Heart Test Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Heart Test Laboratories investors own include Meta Platforms (META), Cardio Diagnostics (CDIO), Invesco QQQ (QQQ), RH (RH), Exxon Mobil (XOM), Amarin (AMRN) and American Express (AXP). Company Calendar Last Earnings12/16/2024Today2/13/2025Next Earnings (Estimated)3/13/2025Fiscal Year End4/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:HSCS CUSIPN/A CIK1468492 Webheartsciences.com Phone682-237-7781FaxN/AEmployees10Year FoundedN/APrice Target and Rating Average Stock Price Target$13.50 High Stock Price Target$15.00 Low Stock Price Target$12.00 Potential Upside/Downside+253.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($7.91) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,610,000.00 Net MarginsN/A Pretax Margin-50,833.34% Return on Equity-117.76% Return on Assets-84.09% Debt Debt-to-Equity Ratio0.01 Current Ratio1.72 Quick Ratio1.52 Sales & Book Value Annual Sales$20,000.00 Price / Sales187.18 Cash FlowN/A Price / Cash FlowN/A Book Value$11.16 per share Price / Book0.34Miscellaneous Outstanding Shares980,000Free Float962,000Market Cap$3.74 million OptionableNot Optionable Beta2.88 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:HSCS) was last updated on 2/13/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.